Medical Congress News

Medical Digest & Congress Report

Health EN ↓ 724 episodes

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.

Author

Medical Congress News

Category

Health

Podcast website

medicaldigest.org

Latest episode

Jun 15, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

DASH-Patterned Groceries Reduce Blood Pressure - report from AHA 2025 03.12.2025

Professor Stephen P. Juraschek discusses the results from the GoFresh randomized clinical trial presented at at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:dash-patterned-groceries-reduce-blood-pressure

TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI - report from AHA 2025 03.12.2025

Professor Sripal Bangalore discusses the findings from the TUXEDO-2 trial presented at at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:tuxedo-2-ticagrelor-vs-prasugrel-patients-diabetes-and-multivessel-disease-after-pci

Aldosterone and Mineralocorticoid Receptors: New Paradigms and Novel Therapies - report from AHA 2025 03.12.2025

Professor John M. Flack shares his insights on the new paradigms and novel therapies in aldosterone and mineralocorticoid receptors at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:aldosterone-and-mineralocorticoid-receptors-new-paradigms-and-novel-therapies

Navigating AHA Scientific Statements: Advancing Evidence-Based Cardiovascular Care - report from AHA 2025 03.12.2025

Professor Bradley S. Marino shares his insights on the advancing evidence-based cardiovascular care at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:navigating-aha-scientific-statements-advancing-evidence-based-cardiovascular-care

A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial - report from AHA 2025 02.12.2025

Professor Heidi T. May explains heart attack risk halved in adults with heart disease taking tailored vitamin D doses at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:randomized-clinical-trial-evaluating-vitamin-d-normalization-major-adverse-cardiovascular-related-events-among-acute-coronary-syndrome-patients-target-d-trial

First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides - report from AHA 2025 02.12.2025

Professor Stephen Nicholls shares his insights on the first-in-human trial of CRISPR gene-editing therapy at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:first-human-trial-crispr-gene-editing-therapy-safely-lowered-cholesterol-triglycerides

Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure - report from AHA 2025 02.12.2025

Professor Stephen Nicholls shares his insights on the pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:once-weekly-tirzepatide-versus-dulaglutide-heart-failure-outcomes-patients-type-2-diabetes-ascvd-and-history-heart-failure

Impact of Cardiovascular-Focused Messaging to Improve Influenza Vaccination on Cardiovascular-Kidney-Metabolic Care Patterns and Clinical Outcomes: Insights from the KP VACCINATE Megatrial 02.12.2025

Professor Ankeet Bhatt shares his insights from the KP VACCINATE Megatrial presented at at AHA Scientific Sessions 2025. Videó: https://medicaldigest.org/scientific-contents/interview:impact-cardiovascular-focused-messaging-improve-influenza-vaccination-cardiovascular-kidney-metabolic-care-patterns-and-clinical-outcomes-insights-kp-vaccinate-megatrial

Resistance Exercise Therapy After COVID-19 Infection: a Randomized, Controlled Trial - report from AHA 2025 02.12.2025

Professor Stuart Gray shares his insights on the resistance exercise therapy after COVID-19 infection at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:resistance-exercise-therapy-after-covid-19-infection-randomized-controlled-trial

Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation - report from AHA 2025 02.12.2025

Professor Amrish Deshmukh shares his insights on metformin as an adjunctive therapy to catheter ablation of atrial fibrillation at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:metformin-adjunctive-therapy-catheter-ablation-atrial-fibrillation

Highlights of AHA / ACC Blood Pressure Management Guideline 02.12.2025

Professor Daniel Jones shares his insights on the AHA / ACC Blood Pressure Management Guideline at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:highlights-aha-acc-blood-pressure-management-guideline

POLY-HF: Daily Polypill Boosts Heart Function, QOL, and Cuts Hospitalizations in Underserved Patients With HFrEF - report from AHA 2025 01.12.2025

Professor Ambarish Pandey presented the data of POLY-HF trial at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:poly-hf-daily-polypill-boosts-heart-function-qol-and-cuts-hospitalizations-underserved-patients-hfref

SOTA-P-CARDIA Trial: A Randomized Trial of Sotagliflozin in HFpEF patients without diabetes - report from AHA 2025 01.12.2025

Professor Juan J. Badimon discusses the SOTA-P-CARDIA Trial, a randomized trial of sotagliflozin in HFpEF patients without diabetes, presented at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:sota-p-cardia-trial-randomized-trial-sotagliflozin-hfpef-patients-without-diabetes

The Clinicians view on the 2025 Guideline for Acute Coronary Syndromes - report from AHA 2025 01.12.2025

Professor Matthew Tomey discusses the clinicians view on the2025 Guideline for Acute Coronary Syndromes at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:clinicians-view-2025-guideline-acute-coronary-syndromes

The New 2025 Guideline for Acute Coronary Syndromes: The European perspective - report from AHA 2025 01.12.2025

Professor Tiziana Claudia Aranzulla shares her insights on the Guideline for Acute Coronary Syndromes from the European perspective at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:new-2025-guideline-acute-coronary-syndromes-european-perspective

State of the art tumor-targeting IL-12 immunocytokine therapies - report from SITC 2025 27.11.2025

Dr. Gregory Conn shares his insights on state of the art tumor-targeting IL-12 immunocytokine therapies after SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-tumor-targeting-il-12-immunocytokine-therapies

Reprogramming the Immune Microenvironment to Intercept Lung Adenocarcinoma Precancer - report from SITC 2025 27.11.2025

Professor Jianjun Zhang shares his insights on reprogramming the immune microenvironment to intercept lung adenocarcinoma precancer at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:reprogramming-immune-microenvironment-intercept-lung-adenocarcinoma-precancer

Primary analysis of patients with high-risk localized, locally recurrent, or regionally advanced cutaneous squamous cell carcinoma treated with neoadjuvant PD-1 therapy - report from SITC 2025 27.11.2025

Professor Gino In presented data from the NeoPOWER trial, to study the role of neoadjuvant PD-1 alone in CSCC at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:primary-analysis-patients-high-risk-localized-locally-recurrent-or-regionally-advanced-cutaneous-squamous-cell-carcinoma-treated-neoadjuvant-pd-1-therapy

Phase I Trial of DOC1021 Cell-Based Immunotherapy for Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma - report from SITC 2025 27.11.2025

Professor William Decker discusses the Phase I Trial of DOC1021 cell-based immunotherapy for resectable or borderline resectable pancreatic ductal adenocarcinoma at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:phase-i-trial-doc1021-cell-based-immunotherapy-resectable-or-borderline-resectable-pancreatic-ductal-adenocarcinoma

How to optimize PD1/PDL1 treatment? - report from SITC 2025 27.11.2025

Professor Gordon J. Freeman shares his insights on how to optimize PD1/PDL1 treatment at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:how-optimize-pd1pdl1-treatment

Modulating the Tumor Microenvironment with T Cell Bispecifics - report from SITC 2025 27.11.2025

Professor Sumit K. Subudhi shares his insights on modulating the tumor microenvironment with T Cell bispecifics at SITC's 40th Anniversary Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:modulating-tumor-microenvironment-t-cell-bispecifics

Comparative Cardioprotective Effects of GLP-1 Receptor Agonists versus SGLT2 Inhibitors in Pulmonary Arterial Hypertension: Insights from a Large-Scale Real-World data analysis 27.11.2025

Dr. Saud Alawad and Prof. Sunil Sharma discuss the comparative cardioprotective effects of GLP-1 receptor agonists versus SGLT2 inhibitors in pulmonary arterial hypertension after the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:comparative-cardioprotective-effects-glp-1-receptor-agonists-versus-sglt2-inhibitors-pu...

Ensifentrine treatment improves COPD symptoms and quality of life in a pooled analysis of the ENHANCE trials - report from CHEST 2025 27.11.2025

Professor Nicola Hanania discuss the lessons from the ENHANCE trials were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:ensifentrine-treatment-improves-copd-symptoms-and-quality-life-pooled-analysis-enhance-trials

Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025 27.11.2025

Dr. Cosmo Fowler explains thet data revealed one-year mortality in patients with type 2 diabetes prescribed GLP-1 RAs was substantially lower than those not prescribed the drugs, and disproportionate benefit for those also diagnosed with OSA. The results were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/inte...

Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis - report from AHA 2025 26.11.2025

Professor Paola Patrignani shares her insights on the advances in the development of therapeutic targets in the platelet for prevention of thrombosis at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:advances-development-therapeutic-targets-platelet-prevention-thrombosis

Listen to the Medical Digest & Congress Report podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.